{"SPADE_UN_17520": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17520", "Peptide Name": "Pleurocidin VA", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GWGSFFKKAAHAGKHAGKAALTHYL", "Sequence Length": 25, "UniProt Entry": ["http://www.uniprot.org/uniprot/P81941"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:HeLa (IC50>400 μg/ml)", "Hemolytic Activity": "Not available", "Cytotoxicity": "HEK293:IC50~400 µg/ml", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C125H184N36O29", "Mass": 2655.02, "PI": 10.18, "Net Charge": 7, "Hydrophobicity": -0.26, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy", "Pubmed ID": "33247193", "Reference": "Commun Biol. 2020 Nov 27;3(1)699.", "Author": "Manzo G, Hind CK, Ferguson PM, Amison RT, Hodgson-Casson AC, Ciazynska KA, Weller BJ, Clarke M, Lam C, Man RCH, Shaughnessy BGO, Clifford M, Bui TT, Drake AF, Atkinson RA, Lam JKW, Pitchford SC, Page CP, Phoenix DA, Lorenz CD, Sutton JM, Mason AJ.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33247193"}], "Frequent Amino Acids": "AGK", "Absent Amino Acids": "CDEIMNOPQRUV", "Basic Residues": 7, "Acidic Residues": 0, "Hydrophobic Residues": 12, "Polar Residues": 16, "Positive Residues": 7, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_17521", "Similarity": 1.0, "Sequence": "GWGSFFKKAAHAGKHAGKAALTHYL"}, {"SPADE_ID": "SPADE_UN_13323", "Similarity": 1.0, "Sequence": "GWSFFKAAHGKHGKAALTHYL"}, {"SPADE_ID": "SPADE_UN_13096", "Similarity": 0.9565217391304348, "Sequence": "GWGSFFKKAAHGKHVGKALTHYL"}]}}}